Lobbying client

SYNZYME TECHNOLOGIES, LLC

Research and development biotechnology firm.

Filings
8
Filed by
1
Reported in-house
—
Reported by firms
—

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2009

Filings

8 filings, newest first.
Filing Filed by Amount
4th Quarter - Termination (No Activity)
4th Quarter 2009
BERKSHIRE, INC. — reported
3rd Quarter - Report
3rd Quarter 2009
BERKSHIRE, INC. — reported
2nd Quarter - Report
2nd Quarter 2009
BERKSHIRE, INC. — reported
1st Quarter - Report
1st Quarter 2009
BERKSHIRE, INC. — reported
Registration - Amendment
1st Quarter 2009
BERKSHIRE, INC. — reported
1st Quarter - Termination (No Activity)
1st Quarter 2008
BERKSHIRE, INC. — reported
Year-End Report
Year-End 2007
BERKSHIRE, INC. — reported
Mid-Year Report
Mid-Year 2007
BERKSHIRE, INC. — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BERKSHIRE, INC. 7 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Budget/Appropriations BUD 4
Defense DEF 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 3326 111th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.